Back to results
US 2023/0416393 A1Published application
Cd6 antibody for treatment of t-cell mediated diseases or disorders
AssigneesThe Cleveland Clinic Foundation, The Regents of the University of Michigan
InventorsFeng Lin, David A. Fox
Life of this patent
Estimating the term…
Abstract
A method of treating a T-cell mediated disease in a subject by administering to the subject a therapeutically effective amount of an antibody or fragment thereof that specifically binds to CD6 is described. Humanized antibodies useful for the method are also described.
Claims10
A method of treating a T-cell mediated disease or disorder in a subject by administering to the subject a therapeutically effective amount of an antibody or fragment thereof that specifically binds to CD6.
Dependencies are inferred from the claim text.